Cargando…
No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409265/ https://www.ncbi.nlm.nih.gov/pubmed/34471967 http://dx.doi.org/10.1007/s10620-021-07214-9 |
| _version_ | 1783746964012138496 |
|---|---|
| author | Li, Weizheng Dong, Yongxue Lei, Xianmei |
| author_facet | Li, Weizheng Dong, Yongxue Lei, Xianmei |
| author_sort | Li, Weizheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8409265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84092652021-09-01 No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews Li, Weizheng Dong, Yongxue Lei, Xianmei Dig Dis Sci Correspondence Springer US 2021-09-01 2022 /pmc/articles/PMC8409265/ /pubmed/34471967 http://dx.doi.org/10.1007/s10620-021-07214-9 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correspondence Li, Weizheng Dong, Yongxue Lei, Xianmei No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews |
| title | No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews |
| title_full | No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews |
| title_fullStr | No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews |
| title_full_unstemmed | No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews |
| title_short | No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews |
| title_sort | no evidence indicates famotidine reduces the risk of serious disease in covid-19 patients after propensity score matching: meta-analysis and systematic reviews |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409265/ https://www.ncbi.nlm.nih.gov/pubmed/34471967 http://dx.doi.org/10.1007/s10620-021-07214-9 |
| work_keys_str_mv | AT liweizheng noevidenceindicatesfamotidinereducestheriskofseriousdiseaseincovid19patientsafterpropensityscorematchingmetaanalysisandsystematicreviews AT dongyongxue noevidenceindicatesfamotidinereducestheriskofseriousdiseaseincovid19patientsafterpropensityscorematchingmetaanalysisandsystematicreviews AT leixianmei noevidenceindicatesfamotidinereducestheriskofseriousdiseaseincovid19patientsafterpropensityscorematchingmetaanalysisandsystematicreviews |